nodes	percent_of_prediction	percent_of_DWPC	metapath
Proguanil—DHFR—bone cancer	0.631	0.859	CbGaD
Proguanil—DHFR—Methotrexate—bone cancer	0.202	0.855	CbGbCtD
Proguanil—CYP3A4—bone cancer	0.103	0.141	CbGaD
Proguanil—CYP2C9—Cisplatin—bone cancer	0.0172	0.0726	CbGbCtD
Proguanil—CYP2D6—Doxorubicin—bone cancer	0.0105	0.0445	CbGbCtD
Proguanil—CYP3A4—Doxorubicin—bone cancer	0.0067	0.0283	CbGbCtD
Proguanil—CYP2E1—Felbamate Metabolism—CYP3A4—bone cancer	0.00243	0.0871	CbGpPWpGaD
Proguanil—DHFR—Folate Metabolism—FOLR1—bone cancer	0.00178	0.0639	CbGpPWpGaD
Proguanil—CYP1A2—Lidocaine metabolism—CYP3A4—bone cancer	0.00146	0.0524	CbGpPWpGaD
Proguanil—CYP2E1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000797	0.0286	CbGpPWpGaD
Proguanil—CYP2C19—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000615	0.0221	CbGpPWpGaD
Proguanil—CYP2D6—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000568	0.0204	CbGpPWpGaD
Proguanil—CYP2D6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000566	0.0203	CbGpPWpGaD
Proguanil—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000561	0.0201	CbGpPWpGaD
Proguanil—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.000536	0.0192	CbGpPWpGaD
Proguanil—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.000536	0.0192	CbGpPWpGaD
Proguanil—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000479	0.0172	CbGpPWpGaD
Proguanil—CYP2E1—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.00046	0.0165	CbGpPWpGaD
Proguanil—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000431	0.0155	CbGpPWpGaD
Proguanil—DHFR—E2F mediated regulation of DNA replication—RB1—bone cancer	0.000389	0.0139	CbGpPWpGaD
Proguanil—CYP2E1—Xenobiotics—CYP3A4—bone cancer	0.000385	0.0138	CbGpPWpGaD
Proguanil—CYP2E1—Tamoxifen metabolism—CYP3A4—bone cancer	0.00037	0.0133	CbGpPWpGaD
Proguanil—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00037	0.0133	CbGpPWpGaD
Proguanil—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000348	0.0125	CbGpPWpGaD
Proguanil—CYP2E1—Metapathway biotransformation—CYP4V2—bone cancer	0.000343	0.0123	CbGpPWpGaD
Proguanil—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000326	0.0117	CbGpPWpGaD
Proguanil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000303	0.0109	CbGpPWpGaD
Proguanil—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.000297	0.0106	CbGpPWpGaD
Proguanil—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.000285	0.0102	CbGpPWpGaD
Proguanil—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000276	0.00992	CbGpPWpGaD
Proguanil—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.000273	0.00979	CbGpPWpGaD
Proguanil—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000271	0.00971	CbGpPWpGaD
Proguanil—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.000265	0.0095	CbGpPWpGaD
Proguanil—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000263	0.00942	CbGpPWpGaD
Proguanil—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.00026	0.00934	CbGpPWpGaD
Proguanil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000259	0.00929	CbGpPWpGaD
Proguanil—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000252	0.00903	CbGpPWpGaD
Proguanil—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.000252	0.00903	CbGpPWpGaD
Proguanil—DHFR—E2F transcription factor network—PLAU—bone cancer	0.000251	0.00899	CbGpPWpGaD
Proguanil—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.000243	0.00873	CbGpPWpGaD
Proguanil—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000241	0.00866	CbGpPWpGaD
Proguanil—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000241	0.00864	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—ZW10—bone cancer	0.000237	0.00851	CbGpPWpGaD
Proguanil—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000231	0.0083	CbGpPWpGaD
Proguanil—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.000222	0.00798	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—ZW10—bone cancer	0.000212	0.00761	CbGpPWpGaD
Proguanil—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000206	0.0074	CbGpPWpGaD
Proguanil—DHFR—E2F transcription factor network—RB1—bone cancer	0.000206	0.00739	CbGpPWpGaD
Proguanil—DHFR—Retinoblastoma (RB) in Cancer—CDK4—bone cancer	0.000206	0.00738	CbGpPWpGaD
Proguanil—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000204	0.00731	CbGpPWpGaD
Proguanil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.0002	0.00717	CbGpPWpGaD
Proguanil—CYP2E1—Tryptophan metabolism—CYP3A4—bone cancer	0.000198	0.00709	CbGpPWpGaD
Proguanil—DHFR—Fluoropyrimidine Activity—TP53—bone cancer	0.00019	0.00682	CbGpPWpGaD
Proguanil—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000186	0.00667	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—TUBB4B—bone cancer	0.00018	0.00645	CbGpPWpGaD
Proguanil—DHFR—Retinoblastoma (RB) in Cancer—RB1—bone cancer	0.000179	0.00642	CbGpPWpGaD
Proguanil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000177	0.00635	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—RFC1—bone cancer	0.000163	0.00585	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—TUBB4B—bone cancer	0.000161	0.00577	CbGpPWpGaD
Proguanil—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00016	0.00573	CbGpPWpGaD
Proguanil—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000159	0.00571	CbGpPWpGaD
Proguanil—CYP2E1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000158	0.00566	CbGpPWpGaD
Proguanil—DHFR—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	0.000153	0.00547	CbGpPWpGaD
Proguanil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000151	0.00543	CbGpPWpGaD
Proguanil—DHFR—G1/S Transition—RB1—bone cancer	0.000149	0.00536	CbGpPWpGaD
Proguanil—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	0.000147	0.00528	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—RFC1—bone cancer	0.000146	0.00523	CbGpPWpGaD
Proguanil—DHFR—Mitotic G1-G1/S phases—CDK4—bone cancer	0.000145	0.00519	CbGpPWpGaD
Proguanil—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.00013	0.00468	CbGpPWpGaD
Proguanil—CYP2E1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000129	0.00465	CbGpPWpGaD
Proguanil—DHFR—Mitotic G1-G1/S phases—RB1—bone cancer	0.000126	0.00452	CbGpPWpGaD
Proguanil—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000123	0.00442	CbGpPWpGaD
Proguanil—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000122	0.00436	CbGpPWpGaD
Proguanil—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000119	0.00426	CbGpPWpGaD
Proguanil—DHFR—Metabolism—NDUFA12—bone cancer	0.000115	0.00414	CbGpPWpGaD
Proguanil—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000113	0.00407	CbGpPWpGaD
Proguanil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000112	0.00403	CbGpPWpGaD
Proguanil—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000112	0.00401	CbGpPWpGaD
Proguanil—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000111	0.00398	CbGpPWpGaD
Proguanil—DHFR—Folate Metabolism—TP53—bone cancer	0.000109	0.00392	CbGpPWpGaD
Proguanil—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	9.99e-05	0.00358	CbGpPWpGaD
Proguanil—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	9.6e-05	0.00345	CbGpPWpGaD
Proguanil—DHFR—Metabolism—NT5C3A—bone cancer	9.56e-05	0.00343	CbGpPWpGaD
Proguanil—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	9.48e-05	0.0034	CbGpPWpGaD
Proguanil—Amylase increased—Cisplatin—bone cancer	9.3e-05	0.0889	CcSEcCtD
Proguanil—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	9.19e-05	0.0033	CbGpPWpGaD
Proguanil—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	9.11e-05	0.00327	CbGpPWpGaD
Proguanil—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	9.08e-05	0.00326	CbGpPWpGaD
Proguanil—DHFR—Retinoblastoma (RB) in Cancer—TP53—bone cancer	8.75e-05	0.00314	CbGpPWpGaD
Proguanil—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	7.78e-05	0.00279	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—CHEK2—bone cancer	7.55e-05	0.00271	CbGpPWpGaD
Proguanil—CYP2E1—Biological oxidations—CYP3A4—bone cancer	6.88e-05	0.00247	CbGpPWpGaD
Proguanil—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	6.78e-05	0.00243	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	6.4e-05	0.0023	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—BRCA2—bone cancer	6.4e-05	0.0023	CbGpPWpGaD
Proguanil—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	6.32e-05	0.00227	CbGpPWpGaD
Proguanil—CYP1A2—Phase II conjugation—GSTP1—bone cancer	6.05e-05	0.00217	CbGpPWpGaD
Proguanil—CYP2E1—Biological oxidations—GSTP1—bone cancer	5.88e-05	0.00211	CbGpPWpGaD
Proguanil—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	5.8e-05	0.00208	CbGpPWpGaD
Proguanil—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	5.76e-05	0.00207	CbGpPWpGaD
Proguanil—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	5.46e-05	0.00196	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—CDK4—bone cancer	5.31e-05	0.00191	CbGpPWpGaD
Proguanil—CYP2C19—Biological oxidations—CYP3A4—bone cancer	5.31e-05	0.0019	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	5.26e-05	0.00189	CbGpPWpGaD
Proguanil—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	5.23e-05	0.00188	CbGpPWpGaD
Proguanil—DHFR—Disease—ENO2—bone cancer	5e-05	0.00179	CbGpPWpGaD
Proguanil—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	4.92e-05	0.00177	CbGpPWpGaD
Proguanil—CYP2D6—Biological oxidations—CYP3A4—bone cancer	4.88e-05	0.00175	CbGpPWpGaD
Proguanil—CYP2C9—Biological oxidations—CYP3A4—bone cancer	4.84e-05	0.00174	CbGpPWpGaD
Proguanil—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	4.81e-05	0.00173	CbGpPWpGaD
Proguanil—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	4.77e-05	0.00171	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—CDK4—bone cancer	4.75e-05	0.0017	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	4.74e-05	0.0017	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—RB1—bone cancer	4.62e-05	0.00166	CbGpPWpGaD
Proguanil—CYP2C19—Biological oxidations—GSTP1—bone cancer	4.54e-05	0.00163	CbGpPWpGaD
Proguanil—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	4.48e-05	0.00161	CbGpPWpGaD
Proguanil—Body temperature increased—Carboplatin—bone cancer	4.26e-05	0.0407	CcSEcCtD
Proguanil—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	4.21e-05	0.00151	CbGpPWpGaD
Proguanil—DHFR—Metabolism—ENO2—bone cancer	4.19e-05	0.0015	CbGpPWpGaD
Proguanil—CYP2D6—Biological oxidations—GSTP1—bone cancer	4.17e-05	0.0015	CbGpPWpGaD
Proguanil—CYP2C9—Biological oxidations—GSTP1—bone cancer	4.14e-05	0.00148	CbGpPWpGaD
Proguanil—CYP1A2—Biological oxidations—CYP3A4—bone cancer	4.14e-05	0.00148	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—RB1—bone cancer	4.13e-05	0.00148	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—NDUFA12—bone cancer	4.12e-05	0.00148	CbGpPWpGaD
Proguanil—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	4.12e-05	0.00148	CbGpPWpGaD
Proguanil—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	4.08e-05	0.00146	CbGpPWpGaD
Proguanil—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	4.08e-05	0.00146	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	3.73e-05	0.00134	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	3.73e-05	0.00134	CbGpPWpGaD
Proguanil—DHFR—Metabolism—GNA11—bone cancer	3.63e-05	0.0013	CbGpPWpGaD
Proguanil—CYP1A2—Biological oxidations—GSTP1—bone cancer	3.54e-05	0.00127	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—MDM2—bone cancer	3.52e-05	0.00126	CbGpPWpGaD
Proguanil—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	3.49e-05	0.00125	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—NT5C3A—bone cancer	3.42e-05	0.00123	CbGpPWpGaD
Proguanil—DHFR—Disease—TGFBR2—bone cancer	3.36e-05	0.00121	CbGpPWpGaD
Proguanil—DHFR—Metabolism—CYP3A4—bone cancer	3.29e-05	0.00118	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—NDUFA12—bone cancer	3.18e-05	0.00114	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NDUFA12—bone cancer	2.93e-05	0.00105	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NDUFA12—bone cancer	2.9e-05	0.00104	CbGpPWpGaD
Proguanil—DHFR—Metabolism—GSTP1—bone cancer	2.81e-05	0.00101	CbGpPWpGaD
Proguanil—CYP3A4—Biological oxidations—GSTP1—bone cancer	2.73e-05	0.000979	CbGpPWpGaD
Proguanil—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	2.69e-05	0.000966	CbGpPWpGaD
Proguanil—Pancytopenia—Cisplatin—bone cancer	2.64e-05	0.0252	CcSEcCtD
Proguanil—CYP2C19—Metabolism—NT5C3A—bone cancer	2.64e-05	0.000946	CbGpPWpGaD
Proguanil—Hepatic enzyme increased—Methotrexate—bone cancer	2.57e-05	0.0246	CcSEcCtD
Proguanil—CYP1A2—Metabolism—NDUFA12—bone cancer	2.48e-05	0.000889	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NT5C3A—bone cancer	2.42e-05	0.00087	CbGpPWpGaD
Proguanil—Stomatitis—Cisplatin—bone cancer	2.41e-05	0.0231	CcSEcCtD
Proguanil—CYP2C9—Metabolism—NT5C3A—bone cancer	2.4e-05	0.000862	CbGpPWpGaD
Proguanil—Hepatobiliary disease—Cisplatin—bone cancer	2.34e-05	0.0224	CcSEcCtD
Proguanil—DHFR—Disease—KIT—bone cancer	2.29e-05	0.000823	CbGpPWpGaD
Proguanil—DHFR—Disease—BRAF—bone cancer	2.16e-05	0.000773	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NT5C3A—bone cancer	2.05e-05	0.000737	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—TP53—bone cancer	2.02e-05	0.000725	CbGpPWpGaD
Proguanil—Immune system disorder—Cisplatin—bone cancer	2.01e-05	0.0192	CcSEcCtD
Proguanil—Mediastinal disorder—Cisplatin—bone cancer	2e-05	0.0192	CcSEcCtD
Proguanil—Erythema—Cisplatin—bone cancer	1.94e-05	0.0185	CcSEcCtD
Proguanil—Malnutrition—Cisplatin—bone cancer	1.94e-05	0.0185	CcSEcCtD
Proguanil—CYP3A4—Metabolism—NDUFA12—bone cancer	1.91e-05	0.000686	CbGpPWpGaD
Proguanil—DHFR—Disease—MDM2—bone cancer	1.81e-05	0.000648	CbGpPWpGaD
Proguanil—DHFR—Disease—PTGS2—bone cancer	1.74e-05	0.000625	CbGpPWpGaD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	1.64e-05	0.0157	CcSEcCtD
Proguanil—CYP3A4—Metabolism—NT5C3A—bone cancer	1.59e-05	0.000569	CbGpPWpGaD
Proguanil—Nervous system disorder—Cisplatin—bone cancer	1.55e-05	0.0148	CcSEcCtD
Proguanil—Skin disorder—Cisplatin—bone cancer	1.53e-05	0.0147	CcSEcCtD
Proguanil—Anorexia—Cisplatin—bone cancer	1.51e-05	0.0144	CcSEcCtD
Proguanil—CYP2E1—Metabolism—ENO2—bone cancer	1.5e-05	0.000537	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PTGS2—bone cancer	1.46e-05	0.000523	CbGpPWpGaD
Proguanil—Pancytopenia—Methotrexate—bone cancer	1.45e-05	0.0138	CcSEcCtD
Proguanil—CYP2E1—Metabolism—DHFR—bone cancer	1.39e-05	0.000498	CbGpPWpGaD
Proguanil—Decreased appetite—Cisplatin—bone cancer	1.37e-05	0.0131	CcSEcCtD
Proguanil—Gastrointestinal disorder—Cisplatin—bone cancer	1.36e-05	0.013	CcSEcCtD
Proguanil—Pancytopenia—Epirubicin—bone cancer	1.35e-05	0.013	CcSEcCtD
Proguanil—Stomatitis—Methotrexate—bone cancer	1.32e-05	0.0127	CcSEcCtD
Proguanil—CYP2E1—Metabolism—GNA11—bone cancer	1.3e-05	0.000466	CbGpPWpGaD
Proguanil—Hepatobiliary disease—Methotrexate—bone cancer	1.29e-05	0.0123	CcSEcCtD
Proguanil—Pancytopenia—Doxorubicin—bone cancer	1.25e-05	0.012	CcSEcCtD
Proguanil—Body temperature increased—Cisplatin—bone cancer	1.25e-05	0.0119	CcSEcCtD
Proguanil—Stomatitis—Epirubicin—bone cancer	1.24e-05	0.0119	CcSEcCtD
Proguanil—DHFR—Disease—EGFR—bone cancer	1.23e-05	0.000443	CbGpPWpGaD
Proguanil—Hepatobiliary disease—Epirubicin—bone cancer	1.2e-05	0.0115	CcSEcCtD
Proguanil—CYP2E1—Metabolism—CYP3A4—bone cancer	1.18e-05	0.000422	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ENO2—bone cancer	1.15e-05	0.000414	CbGpPWpGaD
Proguanil—Stomatitis—Doxorubicin—bone cancer	1.15e-05	0.011	CcSEcCtD
Proguanil—Hepatobiliary disease—Doxorubicin—bone cancer	1.11e-05	0.0106	CcSEcCtD
Proguanil—Immune system disorder—Methotrexate—bone cancer	1.1e-05	0.0105	CcSEcCtD
Proguanil—Mediastinal disorder—Methotrexate—bone cancer	1.1e-05	0.0105	CcSEcCtD
Proguanil—Diarrhoea—Cisplatin—bone cancer	1.08e-05	0.0103	CcSEcCtD
Proguanil—CYP2C19—Metabolism—DHFR—bone cancer	1.07e-05	0.000384	CbGpPWpGaD
Proguanil—Mental disorder—Methotrexate—bone cancer	1.07e-05	0.0102	CcSEcCtD
Proguanil—CYP2D6—Metabolism—ENO2—bone cancer	1.06e-05	0.000381	CbGpPWpGaD
Proguanil—Malnutrition—Methotrexate—bone cancer	1.06e-05	0.0102	CcSEcCtD
Proguanil—Erythema—Methotrexate—bone cancer	1.06e-05	0.0102	CcSEcCtD
Proguanil—CYP2C9—Metabolism—ENO2—bone cancer	1.05e-05	0.000378	CbGpPWpGaD
Proguanil—Immune system disorder—Epirubicin—bone cancer	1.03e-05	0.00986	CcSEcCtD
Proguanil—Mediastinal disorder—Epirubicin—bone cancer	1.03e-05	0.00984	CcSEcCtD
Proguanil—CYP2E1—Metabolism—GSTP1—bone cancer	1.01e-05	0.000361	CbGpPWpGaD
Proguanil—Vomiting—Cisplatin—bone cancer	1e-05	0.00961	CcSEcCtD
Proguanil—CYP2C19—Metabolism—GNA11—bone cancer	1e-05	0.000359	CbGpPWpGaD
Proguanil—Mental disorder—Epirubicin—bone cancer	1e-05	0.00957	CcSEcCtD
Proguanil—Rash—Cisplatin—bone cancer	9.96e-06	0.00953	CcSEcCtD
Proguanil—Dermatitis—Cisplatin—bone cancer	9.95e-06	0.00952	CcSEcCtD
Proguanil—Malnutrition—Epirubicin—bone cancer	9.94e-06	0.00951	CcSEcCtD
Proguanil—Erythema—Epirubicin—bone cancer	9.94e-06	0.00951	CcSEcCtD
Proguanil—CYP2D6—Metabolism—DHFR—bone cancer	9.85e-06	0.000353	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—DHFR—bone cancer	9.77e-06	0.00035	CbGpPWpGaD
Proguanil—Immune system disorder—Doxorubicin—bone cancer	9.54e-06	0.00913	CcSEcCtD
Proguanil—Mediastinal disorder—Doxorubicin—bone cancer	9.52e-06	0.00911	CcSEcCtD
Proguanil—Nausea—Cisplatin—bone cancer	9.38e-06	0.00897	CcSEcCtD
Proguanil—Cough—Methotrexate—bone cancer	9.27e-06	0.00886	CcSEcCtD
Proguanil—Mental disorder—Doxorubicin—bone cancer	9.25e-06	0.00885	CcSEcCtD
Proguanil—CYP2D6—Metabolism—GNA11—bone cancer	9.21e-06	0.00033	CbGpPWpGaD
Proguanil—Erythema—Doxorubicin—bone cancer	9.19e-06	0.0088	CcSEcCtD
Proguanil—Malnutrition—Doxorubicin—bone cancer	9.19e-06	0.0088	CcSEcCtD
Proguanil—CYP2C9—Metabolism—GNA11—bone cancer	9.13e-06	0.000328	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CYP3A4—bone cancer	9.08e-06	0.000326	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	9.03e-06	0.000324	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ENO2—bone cancer	9e-06	0.000323	CbGpPWpGaD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	8.98e-06	0.00859	CcSEcCtD
Proguanil—Cough—Epirubicin—bone cancer	8.67e-06	0.0083	CcSEcCtD
Proguanil—Nervous system disorder—Methotrexate—bone cancer	8.5e-06	0.00813	CcSEcCtD
Proguanil—Skin disorder—Methotrexate—bone cancer	8.42e-06	0.00805	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	8.4e-06	0.00804	CcSEcCtD
Proguanil—CYP2D6—Metabolism—CYP3A4—bone cancer	8.35e-06	0.0003	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—DHFR—bone cancer	8.35e-06	0.000299	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYP3A4—bone cancer	8.28e-06	0.000297	CbGpPWpGaD
Proguanil—Anorexia—Methotrexate—bone cancer	8.26e-06	0.0079	CcSEcCtD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	8.23e-06	0.000295	CbGpPWpGaD
Proguanil—Cough—Doxorubicin—bone cancer	8.02e-06	0.00768	CcSEcCtD
Proguanil—Nervous system disorder—Epirubicin—bone cancer	7.95e-06	0.00761	CcSEcCtD
Proguanil—Skin disorder—Epirubicin—bone cancer	7.88e-06	0.00754	CcSEcCtD
Proguanil—CYP1A2—Metabolism—GNA11—bone cancer	7.8e-06	0.00028	CbGpPWpGaD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	7.77e-06	0.00744	CcSEcCtD
Proguanil—CYP2C19—Metabolism—GSTP1—bone cancer	7.76e-06	0.000279	CbGpPWpGaD
Proguanil—Anorexia—Epirubicin—bone cancer	7.73e-06	0.0074	CcSEcCtD
Proguanil—Decreased appetite—Methotrexate—bone cancer	7.53e-06	0.00721	CcSEcCtD
Proguanil—Gastrointestinal disorder—Methotrexate—bone cancer	7.48e-06	0.00716	CcSEcCtD
Proguanil—Nervous system disorder—Doxorubicin—bone cancer	7.36e-06	0.00704	CcSEcCtD
Proguanil—Skin disorder—Doxorubicin—bone cancer	7.29e-06	0.00697	CcSEcCtD
Proguanil—Anorexia—Doxorubicin—bone cancer	7.15e-06	0.00684	CcSEcCtD
Proguanil—CYP2D6—Metabolism—GSTP1—bone cancer	7.14e-06	0.000256	CbGpPWpGaD
Proguanil—Gastrointestinal pain—Methotrexate—bone cancer	7.09e-06	0.00678	CcSEcCtD
Proguanil—CYP2C9—Metabolism—GSTP1—bone cancer	7.08e-06	0.000254	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP3A4—bone cancer	7.07e-06	0.000254	CbGpPWpGaD
Proguanil—Decreased appetite—Epirubicin—bone cancer	7.05e-06	0.00674	CcSEcCtD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.04e-06	0.000252	CbGpPWpGaD
Proguanil—Gastrointestinal disorder—Epirubicin—bone cancer	7e-06	0.0067	CcSEcCtD
Proguanil—CYP3A4—Metabolism—ENO2—bone cancer	6.94e-06	0.000249	CbGpPWpGaD
Proguanil—Abdominal pain—Methotrexate—bone cancer	6.85e-06	0.00655	CcSEcCtD
Proguanil—Body temperature increased—Methotrexate—bone cancer	6.85e-06	0.00655	CcSEcCtD
Proguanil—Gastrointestinal pain—Epirubicin—bone cancer	6.63e-06	0.00634	CcSEcCtD
Proguanil—Decreased appetite—Doxorubicin—bone cancer	6.52e-06	0.00624	CcSEcCtD
Proguanil—Gastrointestinal disorder—Doxorubicin—bone cancer	6.48e-06	0.0062	CcSEcCtD
Proguanil—CYP3A4—Metabolism—DHFR—bone cancer	6.44e-06	0.000231	CbGpPWpGaD
Proguanil—Body temperature increased—Epirubicin—bone cancer	6.41e-06	0.00613	CcSEcCtD
Proguanil—Abdominal pain—Epirubicin—bone cancer	6.41e-06	0.00613	CcSEcCtD
Proguanil—Gastrointestinal pain—Doxorubicin—bone cancer	6.14e-06	0.00587	CcSEcCtD
Proguanil—CYP1A2—Metabolism—GSTP1—bone cancer	6.05e-06	0.000217	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GNA11—bone cancer	6.02e-06	0.000216	CbGpPWpGaD
Proguanil—Body temperature increased—Doxorubicin—bone cancer	5.93e-06	0.00568	CcSEcCtD
Proguanil—Abdominal pain—Doxorubicin—bone cancer	5.93e-06	0.00568	CcSEcCtD
Proguanil—Diarrhoea—Methotrexate—bone cancer	5.93e-06	0.00567	CcSEcCtD
Proguanil—Diarrhoea—Epirubicin—bone cancer	5.55e-06	0.00531	CcSEcCtD
Proguanil—Vomiting—Methotrexate—bone cancer	5.51e-06	0.00527	CcSEcCtD
Proguanil—Rash—Methotrexate—bone cancer	5.46e-06	0.00523	CcSEcCtD
Proguanil—Dermatitis—Methotrexate—bone cancer	5.46e-06	0.00522	CcSEcCtD
Proguanil—Headache—Methotrexate—bone cancer	5.43e-06	0.00519	CcSEcCtD
Proguanil—CYP2E1—Metabolism—PTGS2—bone cancer	5.21e-06	0.000187	CbGpPWpGaD
Proguanil—Vomiting—Epirubicin—bone cancer	5.16e-06	0.00493	CcSEcCtD
Proguanil—Nausea—Methotrexate—bone cancer	5.15e-06	0.00492	CcSEcCtD
Proguanil—Diarrhoea—Doxorubicin—bone cancer	5.13e-06	0.00491	CcSEcCtD
Proguanil—Rash—Epirubicin—bone cancer	5.11e-06	0.00489	CcSEcCtD
Proguanil—Dermatitis—Epirubicin—bone cancer	5.11e-06	0.00489	CcSEcCtD
Proguanil—Headache—Epirubicin—bone cancer	5.08e-06	0.00486	CcSEcCtD
Proguanil—Nausea—Epirubicin—bone cancer	4.82e-06	0.00461	CcSEcCtD
Proguanil—Vomiting—Doxorubicin—bone cancer	4.77e-06	0.00456	CcSEcCtD
Proguanil—Rash—Doxorubicin—bone cancer	4.73e-06	0.00453	CcSEcCtD
Proguanil—Dermatitis—Doxorubicin—bone cancer	4.73e-06	0.00452	CcSEcCtD
Proguanil—Headache—Doxorubicin—bone cancer	4.7e-06	0.0045	CcSEcCtD
Proguanil—CYP3A4—Metabolism—GSTP1—bone cancer	4.67e-06	0.000167	CbGpPWpGaD
Proguanil—Nausea—Doxorubicin—bone cancer	4.46e-06	0.00426	CcSEcCtD
Proguanil—CYP2C19—Metabolism—PTGS2—bone cancer	4.02e-06	0.000144	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PTGS2—bone cancer	3.7e-06	0.000133	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PTGS2—bone cancer	3.67e-06	0.000132	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PTGS2—bone cancer	3.13e-06	0.000112	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PTGS2—bone cancer	2.42e-06	8.68e-05	CbGpPWpGaD
